Top Markets
Coin of the day
BioSenic S.A. BioSenic S.A.

BioSenic S.A.

BIOS
Rangering i aksjer #37641
BioSenic S.A., a biotechnology company located in Mont-Saint-Guibert, Belgium,... BioSenic S.A., a biotechnology company located in Mont-Saint-Guibert, Belgium, is dedicated to progressing clinical therapeutic solutions. The firm utilizes two primary technology platforms: an innovative allogeneic cell and gene therapy system featuring distinct bone marrow-derived mesenchymal stromal cells designed for convenient on-site hospital storage; and an Arsenic Trioxide platform. The latter is deployed in immuno-oncology to target illnesses such as graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's leading experimental drug, ALLOB, is currently undergoing a Phase IIb clinical trial for patients with complicated tibial fractures.
Aksjekurs
$0.00237231
Sist synkronisert: 2026-06-22
Markedsverdi
$1.55M
Endring (1 dag)
0.00%
Endring (1 år)
-18.94%
Land
BE
Handel BioSenic S.A. (BIOS)

Kategori

Utbytteavkastning for BioSenic S.A. (BIOS)
BioSenic S.A. (aksjesymbol: BIOS) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for BioSenic S.A. (BIOS) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter